CDRH (Center for Devices and Radiological Health) mulls labelling change
This article was originally published in Clinica
Executive Summary
The FDA may rethink its product labelling requirements, according to David Feigal, director of the Center for Devices and Radiological Health. Dr Feigal said at the annual meeting of AdvaMed, the Advanced Medical Technology Association in Palm Springs, California last month (see Clinica No 952, p 11), that the morass of labelling now required as part of a product insert is "an area that is really ripe for change".